Menarini Silicon Biosystems, a pioneer of cell-based liquid biopsy technology, announced today the publication in Clinical Cancer Research[1] of the CTC biomarker analysis from the PACE trial, a ...

CXCL12 and CXCL13 are potential biomarkers for RSV bronchiolitis severity and recurrence risk, with elevated levels ...

A blood biomarker yet to be used in cardiac arrest care can give a clearer picture of the extent of brain damage after a cardiac arrest.

Jonathan Thompson, MD, MS, emphasized that comprehensive biomarker testing with next-generation sequencing and PD-L1 analysis—implemented as reflex testing at biopsy—is essential to guide precision ...

Lunit’s new collaboration with Daiichi Sankyo integrates AI-driven digital pathology tools into oncology translational ...

Biomarkers are quantifiable compounds that can determine human health status and potentially detect the presence of disease in the body. In clinical settings, routine procedures detect, measure, and ...

To improve ovarian cancer screening, researchers led by Johns Hopkins University’s Victor E. Velculescu, MD, PhD, developed a combination liquid biopsy approach. It has three components: measurements ...

The Translational Research Institute for Space Health (TRISH) at Baylor College of Medicine’s Center for Space Medicine, with consortium partners California Institute of Technology and Massachusetts ...

Skinobs’ founder and CEO Anne Charpentier examines how biomarker-based diagnostics are reshaping dermocosmetics and personalised beauty ...

Collaboration to leverage Lunit SCOPE IO ® and SCOPE universal IHC® (uIHC) digital pathology products in two Daiichi Sankyo oncology research ...